Modular approaches, which allow a systematic variation of heteroaromatic cores and substituents, are crucial for the development of heteroaromatic drug candidates and organic functional materials. A new strategy involving the cyclization of heteroarenes tethered with alkynes through a norbornene bridge was developed. The precursors were readily prepared by a three‐component coupling process of heteroaryl halides, norbornadiene, and terminal alkynes. The Pd catalytic system derived from Pd(OAc)2 and 2‐(pyrazol‐1‐yl)pyridine transformed a variety of five‐membered heteroarenes to the corresponding benzofused products, including (di)benzothiophene, indazole, carbazole, indole, and benzofuran, with aryl and alkyl substituents at the C4(C7) position. During the cyclization process, the norbornene ring underwent a retro‐Diels‐Alder reaction, serving as an acetylene synthon. This approach was used to synthesize naphthalene derivatives from electron‐rich arenes, demonstrating its versatility in the annulation of (hetero)aromatic rings.
Pd-catalyzed alkenylations of metallocenes via C–H activation were developed using electronically tunable pyrazolonaphthyridine (PzNPy) ligands. Ferrocene was alkenylated using the most electron-deficient ligand in the series, whereas the less reactive...
As an alternative to a stoichiometric metal oxidant, oxygen was used as an oxidant for Pd‐catalyzed annulation reactions of pyrazoles with internal alkynes. The addition of sodium acetate and acetic acid was critical for stabilizing the Pd system. This green approach allowed the preparation of indazoles from readily available parent pyrazoles in a single step.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.